Insight of a Metabolic Prognostic Model to Identify Tumor Environment and Drug Vulnerability for Lung Adenocarcinoma
出版年份 2022 全文链接
标题
Insight of a Metabolic Prognostic Model to Identify Tumor Environment and Drug Vulnerability for Lung Adenocarcinoma
作者
关键词
-
出版物
Frontiers in Immunology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-06-23
DOI
10.3389/fimmu.2022.872910
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy
- (2022) Evelien A. J. van Genugten et al. Frontiers in Oncology
- Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux
- (2022) Brandon C. Jones et al. CANCER AND METASTASIS REVIEWS
- Prognostic values, ceRNA network, and immune regulation function of SDPR in KRAS-mutant lung cancer
- (2021) Xiaoqing Luo et al. Cancer Cell International
- DTYMK promote hepatocellular carcinoma proliferation by regulating cell cycle
- (2021) Tianhao Zhou et al. CELL CYCLE
- Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy
- (2021) Jie Mei et al. Journal of Inflammation Research
- Contribution of Lipid Oxidation and Ferroptosis to Radiotherapy Efficacy
- (2021) Ashley N. Pearson et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pattern of Recurrence Analysis in Metastatic EGFR-Mutant NSCLC Treated with Osimertinib: Implications for Consolidative Stereotactic Body Radiation Therapy
- (2020) Tiantian Guo et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- TIMER2.0 for analysis of tumor-infiltrating immune cells
- (2020) Taiwen Li et al. NUCLEIC ACIDS RESEARCH
- Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
- (2020) Sreya Bagchi et al. Annual Review of Pathology-Mechanisms of Disease
- The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets
- (2020) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Hsa_circ_0016760 exacerbates the malignant development of non‑small cell lung cancer by sponging miR‑145‑5p/FGF5
- (2020) Zheng Zhu et al. ONCOLOGY REPORTS
- Engineering IL-2 to Give New Life to T Cell Immunotherapy
- (2020) Willem W. Overwijk et al. Annual Review of Medicine
- Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
- (2019) Michael Platten et al. NATURE REVIEWS DRUG DISCOVERY
- UDP-glucose accelerates SNAI1 mRNA decay and impairs lung cancer metastasis
- (2019) Xiongjun Wang et al. NATURE
- PRMTs and Arginine Methylation: Cancer’s Best-Kept Secret?
- (2019) James Jarrold et al. TRENDS IN MOLECULAR MEDICINE
- BIBR1532, a Selective Telomerase Inhibitor, Enhances Radiosensitivity of Non-Small Cell Lung Cancer Through Increasing Telomere Dysfunction and ATM/CHK1 Inhibition
- (2019) Xiaofeng Ding et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells
- (2019) Pei-Hsuan Chen et al. MOLECULAR CELL
- Tumor Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation.
- (2019) Patricia Fernandez-Nogueira et al. CLINICAL CANCER RESEARCH
- EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression
- (2019) Shunli Peng et al. Molecular Cancer
- The therapeutic potential of targeting tryptophan catabolism in cancer
- (2019) Christiane A. Opitz et al. BRITISH JOURNAL OF CANCER
- A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells
- (2019) Hee Chan Yoo et al. Cell Metabolism
- Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect
- (2018) Linchong Sun et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential
- (2018) Liqin Wang et al. CELL
- Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours
- (2018) Javier Garcia-Bermudez et al. NATURE CELL BIOLOGY
- Aspartate is an endogenous metabolic limitation for tumour growth
- (2018) Lucas B. Sullivan et al. NATURE CELL BIOLOGY
- xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
- (2018) Xiangming Ji et al. ONCOGENE
- Wnt signaling induces radioresistance through upregulating HMGB1 in esophageal squamous cell carcinoma
- (2018) Yuanyuan Zhao et al. Cell Death & Disease
- Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis
- (2018) Alexandre Vallée et al. Frontiers in Immunology
- Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer
- (2018) Puneeth Iyengar et al. JAMA Oncology
- Natural and modified IL-2 for the treatment of cancer and autoimmune diseases
- (2018) Masayuki Mizui CLINICAL IMMUNOLOGY
- Inhibition of NF-κB improves sensitivity to irradiation and EGFR-TKIs and decreases irradiation-induced lung toxicity
- (2018) Rong Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Downregulation of fibroblast growth factor 5 inhibits cell growth and invasion of human nonsmall-cell lung cancer cells
- (2018) Yanjuan Zhou et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Manipulation of Glucose and Hydroperoxide Metabolism to Improve Radiation Response
- (2018) John M. Floberg et al. SEMINARS IN RADIATION ONCOLOGY
- Targeting Hypoxia to Improve Non–Small Cell Lung Cancer Outcome
- (2017) Ahmed Salem et al. JNCI-Journal of the National Cancer Institute
- Targeting Hypoxia to Improve Non–Small Cell Lung Cancer Outcome
- (2017) Ahmed Salem et al. JNCI-Journal of the National Cancer Institute
- Radiotherapy combination opportunities leveraging immunity for the next oncology practice
- (2016) Fernanda G. Herrera et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Role of NF-κB Inhibitors in Cell Response to Radiation
- (2016) Sajjad Molavi Pordanjani et al. CURRENT MEDICINAL CHEMISTRY
- Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment
- (2015) S. Bazzocco et al. CLINICAL CANCER RESEARCH
- Metabolic pathways promoting cancer cell survival and growth
- (2015) Lindsey K. Boroughs et al. NATURE CELL BIOLOGY
- Butyrate and Colorectal Cancer: The Role of Butyrate Transport
- (2013) Pedro Gonçalves et al. CURRENT DRUG METABOLISM
- New Radiotherapy and Chemoradiotherapy Approaches for Non–Small-Cell Lung Cancer
- (2013) Joseph K. Salama et al. JOURNAL OF CLINICAL ONCOLOGY
- Metabolic and Functional Genomic Studies Identify Deoxythymidylate Kinase as a Target in LKB1-Mutant Lung Cancer
- (2013) Y. Liu et al. Cancer Discovery
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started